75.72
-0.01%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Fujian Cosunter Pharmaceutical Co
Its shares trade on Shenzhen under the ticker 300436.SZ. It has been listed since 23 April 2015. In the fiscal year to 31 December 2025, it reported revenue of CN¥416.4m and a net loss of CN¥217.8m. At that date it held total assets of CN¥1.40bn and shareholders' equity of CN¥277.5m.
Fujian Cosunter Pharmaceutical Co., Ltd. engages in medical research and development and the manufacturing and sale of pharmaceutical drugs. The company is headquartered in Fuzhou, Fujian. The company went IPO on 2015-04-23. The firm's major products include Adefovir Dipivoxil Tablets, Lamivudine Tablets, Entecavir Capsules and other nucleoside anti-HBV drugs. The firm also produces over-the-counter (OTC) drugs, such as ferrous fumarate and ganoderma capsules.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 23 Apr 2015
- Employees
- 908
- Website
- cosunter.com ↗
Leadership
Pay as last reported
- Mr. Guoping LiChairman of the Board, General Manager, since 2020CN¥100,000
- Mr. Jianhui GuanChief Financial OfficerCN¥541,400
- Mr. Fuhu HuangChief Operating Officer, DirectorCN¥1.3m
- Dr. Ke HuChief Scientific Officer
- Mr. Qinghe ZhangDeputy General Manager, Secretary of the Board
- Mr. Chenming ZhuangDeputy General Manager, Director, since 2024
- Mr. Yanru HuDeputy General Manager
- Mr. Bingxiang ZengDeputy General ManagerCN¥485,800
- Mr. Guodong LiDirector, since 2024CN¥434,600
- Ms. Liqing YeDirector
- Mr. Fengmin LuIndependent Director
- Ms. Feimei WuIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Fujian Cosunter Pharmaceutical Co Ltd employs 908 full-time employees in Fuzhou, CN.
- The company manufactures Adefovir Dipivoxil Tablets and Lamivudine Tablets for anti-HBV treatment.
- Fujian Cosunter produces over-the-counter drugs including ferrous fumarate and ganoderma capsules.
Weaknesses
- Fujian Cosunter Pharmaceutical Co Ltd is headquartered in Fuzhou, CN, a city with limited global pharmaceutical market access.
- The company's business focuses on nucleoside anti-HBV drugs with limited product diversity.
- Fujian Cosunter's products are primarily sold within China, restricting international expansion.
Opportunities
- Fujian Cosunter Pharmaceutical Co Ltd can expand its OTC drug portfolio with ferrous fumarate and ganoderma capsules.
- The company may leverage its R&D capabilities to develop new anti-HBV treatments in the Health Care sector.
- Fujian Cosunter can explore partnerships to enter international markets beyond China.
Threats
- Fujian Cosunter Pharmaceutical Co Ltd faces competition from other Chinese pharmaceutical companies in the Health Care sector.
- The company's reliance on nucleoside anti-HBV drugs exposes it to market saturation risks.
- Fujian Cosunter's limited international presence makes it vulnerable to domestic regulatory changes in China.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.